148 related articles for article (PubMed ID: 3136549)
21. Effects of L-beta-N-methylamino-L-alanine (L-BMAA) on the cortical cholinergic and glutamatergic systems of the rat.
Rakonczay Z; Matsuoka Y; Giacobini E
J Neurosci Res; 1991 May; 29(1):121-6. PubMed ID: 1653366
[TBL] [Abstract][Full Text] [Related]
22. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo.
Buenz EJ; Howe CL
Neurotoxicology; 2007 May; 28(3):702-4. PubMed ID: 17379313
[TBL] [Abstract][Full Text] [Related]
23. The dietary excitotoxins beta-N-methylamino-L-alanine and beta-N-oxalylamino-L-alanine induce necrotic- and apoptotic-like death of rat cerebellar granule cells.
Staton PC; Bristow DR
J Neurochem; 1997 Oct; 69(4):1508-18. PubMed ID: 9326280
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis induced by beta-N-oxalylamino-L-alanine on a motoneuron hybrid cell line.
La Bella V; Alexianu ME; Colom LV; Ionescu A; Mohamed AH; Appel SH
Neuroscience; 1996 Feb; 70(4):1039-52. PubMed ID: 8848166
[TBL] [Abstract][Full Text] [Related]
25. Beta-N-methylamino-L-alanine. Chronic oral administration is not neurotoxic to mice.
Perry TL; Bergeron C; Biro AJ; Hansen S
J Neurol Sci; 1989 Dec; 94(1-3):173-80. PubMed ID: 2614465
[TBL] [Abstract][Full Text] [Related]
26. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
Kisby GE; Ellison M; Spencer PS
Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
[TBL] [Abstract][Full Text] [Related]
27. Discovery and partial characterization of primate motor-system toxins.
Spencer PS; Hugon J; Ludolph A; Nunn PB; Ross SM; Roy DN; Schaumburg HH
Ciba Found Symp; 1987; 126():221-38. PubMed ID: 3107939
[TBL] [Abstract][Full Text] [Related]
28. Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.
Tan VX; Lassus B; Lim CK; Tixador P; Courte J; Bessede A; Guillemin GJ; Peyrin JM
Neurotox Res; 2018 Jan; 33(1):62-75. PubMed ID: 28842862
[TBL] [Abstract][Full Text] [Related]
29. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of beta-N-methylamino-L-alanine induced neurotoxicity.
Lobner D
Amyotroph Lateral Scler; 2009; 10 Suppl 2():56-60. PubMed ID: 19929733
[TBL] [Abstract][Full Text] [Related]
31. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
32. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
Banack SA; Cox PA
Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
[TBL] [Abstract][Full Text] [Related]
33. BMAA and Neurodegenerative Illness.
Cox PA; Kostrzewa RM; Guillemin GJ
Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
[TBL] [Abstract][Full Text] [Related]
34. ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca
Petrozziello T; Secondo A; Tedeschi V; Esposito A; Sisalli M; Scorziello A; Di Renzo G; Annunziato L
Cell Death Differ; 2017 Mar; 24(3):511-522. PubMed ID: 28085149
[TBL] [Abstract][Full Text] [Related]
35. [Protective effect of tetrandrine on neuronal injury in cultured cortical neurons of rats].
Che JT; Zhang JT; Qu ZW
Yao Xue Xue Bao; 1996; 31(3):161-5. PubMed ID: 9206263
[TBL] [Abstract][Full Text] [Related]
36. The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats.
Engskog MK; Karlsson O; Haglöf J; Elmsjö A; Brittebo E; Arvidsson T; Pettersson C
Toxicology; 2013 Oct; 312():6-11. PubMed ID: 23886855
[TBL] [Abstract][Full Text] [Related]
37. Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid.
Nunn PB
Amyotroph Lateral Scler; 2009; 10 Suppl 2():26-33. PubMed ID: 19929728
[TBL] [Abstract][Full Text] [Related]
38. Interaction between beta-N-methylamino-L-alanine and excitatory amino acid receptors in brain slices and neuronal cultures.
Copani A; Canonico PL; Catania MV; Aronica E; Bruno V; Ratti E; van Amsterdam FT; Gaviraghi G; Nicoletti F
Brain Res; 1991 Aug; 558(1):79-86. PubMed ID: 1657313
[TBL] [Abstract][Full Text] [Related]
39. Novel NMDA receptor-specific desensitization/inactivation produced by ingestion of the neurotoxins, β-N-methylamino-L-alanine (BMAA) or β-N-oxalylamino-L-alanine (BOAA/β-ODAP).
Koenig JH; Goto JJ; Ikeda K
Comp Biochem Physiol C Toxicol Pharmacol; 2015 Jan; 167():43-50. PubMed ID: 25193276
[TBL] [Abstract][Full Text] [Related]
40. Selective death of cholinergic neurons induced by beta-methylamino-L-alanine.
Liu XQ; Rush T; Ciske J; Lobner D
Neuroreport; 2010 Jan; 21(1):55-8. PubMed ID: 19934780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
